1 Study Coverage
    1.1 Amifampridine Product Introduction
    1.2 Market by Type
        1.2.1 Global Amifampridine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Generic
        1.2.3 Patent
    1.3 Market by Application
        1.3.1 Global Amifampridine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Myasthenia Gravis
        1.3.3 Potassium Channel Blocker
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Amifampridine Sales Estimates and Forecasts 2017-2028
    2.2 Global Amifampridine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Amifampridine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Amifampridine Sales by Region
        2.4.1 Global Amifampridine Sales by Region (2017-2022)
        2.4.2 Global Sales Amifampridine by Region (2023-2028)
    2.5 Global Amifampridine Revenue by Region
        2.5.1 Global Amifampridine Revenue by Region (2017-2022)
        2.5.2 Global Amifampridine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Amifampridine Sales by Manufacturers
        3.1.1 Global Top Amifampridine Manufacturers by Sales (2017-2022)
        3.1.2 Global Amifampridine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amifampridine in 2021
    3.2 Global Amifampridine Revenue by Manufacturers
        3.2.1 Global Amifampridine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Amifampridine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Amifampridine Revenue in 2021
    3.3 Global Amifampridine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Amifampridine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Amifampridine Sales by Type
        4.1.1 Global Amifampridine Historical Sales by Type (2017-2022)
        4.1.2 Global Amifampridine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Amifampridine Sales Market Share by Type (2017-2028)
    4.2 Global Amifampridine Revenue by Type
        4.2.1 Global Amifampridine Historical Revenue by Type (2017-2022)
        4.2.2 Global Amifampridine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Amifampridine Revenue Market Share by Type (2017-2028)
    4.3 Global Amifampridine Price by Type
        4.3.1 Global Amifampridine Price by Type (2017-2022)
        4.3.2 Global Amifampridine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Amifampridine Sales by Application
        5.1.1 Global Amifampridine Historical Sales by Application (2017-2022)
        5.1.2 Global Amifampridine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Amifampridine Sales Market Share by Application (2017-2028)
    5.2 Global Amifampridine Revenue by Application
        5.2.1 Global Amifampridine Historical Revenue by Application (2017-2022)
        5.2.2 Global Amifampridine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Amifampridine Revenue Market Share by Application (2017-2028)
    5.3 Global Amifampridine Price by Application
        5.3.1 Global Amifampridine Price by Application (2017-2022)
        5.3.2 Global Amifampridine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Amifampridine Market Size by Type
        6.1.1 North America Amifampridine Sales by Type (2017-2028)
        6.1.2 North America Amifampridine Revenue by Type (2017-2028)
    6.2 North America Amifampridine Market Size by Application
        6.2.1 North America Amifampridine Sales by Application (2017-2028)
        6.2.2 North America Amifampridine Revenue by Application (2017-2028)
    6.3 North America Amifampridine Market Size by Country
        6.3.1 North America Amifampridine Sales by Country (2017-2028)
        6.3.2 North America Amifampridine Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Amifampridine Market Size by Type
        7.1.1 Europe Amifampridine Sales by Type (2017-2028)
        7.1.2 Europe Amifampridine Revenue by Type (2017-2028)
    7.2 Europe Amifampridine Market Size by Application
        7.2.1 Europe Amifampridine Sales by Application (2017-2028)
        7.2.2 Europe Amifampridine Revenue by Application (2017-2028)
    7.3 Europe Amifampridine Market Size by Country
        7.3.1 Europe Amifampridine Sales by Country (2017-2028)
        7.3.2 Europe Amifampridine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Amifampridine Market Size by Type
        8.1.1 Asia Pacific Amifampridine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Amifampridine Revenue by Type (2017-2028)
    8.2 Asia Pacific Amifampridine Market Size by Application
        8.2.1 Asia Pacific Amifampridine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Amifampridine Revenue by Application (2017-2028)
    8.3 Asia Pacific Amifampridine Market Size by Region
        8.3.1 Asia Pacific Amifampridine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Amifampridine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Amifampridine Market Size by Type
        9.1.1 Latin America Amifampridine Sales by Type (2017-2028)
        9.1.2 Latin America Amifampridine Revenue by Type (2017-2028)
    9.2 Latin America Amifampridine Market Size by Application
        9.2.1 Latin America Amifampridine Sales by Application (2017-2028)
        9.2.2 Latin America Amifampridine Revenue by Application (2017-2028)
    9.3 Latin America Amifampridine Market Size by Country
        9.3.1 Latin America Amifampridine Sales by Country (2017-2028)
        9.3.2 Latin America Amifampridine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Amifampridine Market Size by Type
        10.1.1 Middle East and Africa Amifampridine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Amifampridine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Amifampridine Market Size by Application
        10.2.1 Middle East and Africa Amifampridine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Amifampridine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Amifampridine Market Size by Country
        10.3.1 Middle East and Africa Amifampridine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Amifampridine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Jacobus Pharmaceutical
        11.1.1 Jacobus Pharmaceutical Corporation Information
        11.1.2 Jacobus Pharmaceutical Overview
        11.1.3 Jacobus Pharmaceutical Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Jacobus Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Jacobus Pharmaceutical Recent Developments
    11.2 Unichem
        11.2.1 Unichem Corporation Information
        11.2.2 Unichem Overview
        11.2.3 Unichem Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Unichem Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Unichem Recent Developments
    11.3 BioMarin Pharmaceutical
        11.3.1 BioMarin Pharmaceutical Corporation Information
        11.3.2 BioMarin Pharmaceutical Overview
        11.3.3 BioMarin Pharmaceutical Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 BioMarin Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 BioMarin Pharmaceutical Recent Developments
    11.4 Wockhardt
        11.4.1 Wockhardt Corporation Information
        11.4.2 Wockhardt Overview
        11.4.3 Wockhardt Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Wockhardt Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Wockhardt Recent Developments
    11.5 Glenmark Pharmaceuticals
        11.5.1 Glenmark Pharmaceuticals Corporation Information
        11.5.2 Glenmark Pharmaceuticals Overview
        11.5.3 Glenmark Pharmaceuticals Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Glenmark Pharmaceuticals Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Glenmark Pharmaceuticals Recent Developments
    11.6 Norris Pharm
        11.6.1 Norris Pharm Corporation Information
        11.6.2 Norris Pharm Overview
        11.6.3 Norris Pharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Norris Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Norris Pharm Recent Developments
    11.7 BLD Pharm
        11.7.1 BLD Pharm Corporation Information
        11.7.2 BLD Pharm Overview
        11.7.3 BLD Pharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 BLD Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 BLD Pharm Recent Developments
    11.8 Biosynth AG
        11.8.1 Biosynth AG Corporation Information
        11.8.2 Biosynth AG Overview
        11.8.3 Biosynth AG Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Biosynth AG Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Biosynth AG Recent Developments
    11.9 Innovapharm
        11.9.1 Innovapharm Corporation Information
        11.9.2 Innovapharm Overview
        11.9.3 Innovapharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Innovapharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Innovapharm Recent Developments
    11.10 Founder Pharma
        11.10.1 Founder Pharma Corporation Information
        11.10.2 Founder Pharma Overview
        11.10.3 Founder Pharma Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Founder Pharma Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Founder Pharma Recent Developments
    11.11 BroadPharm
        11.11.1 BroadPharm Corporation Information
        11.11.2 BroadPharm Overview
        11.11.3 BroadPharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 BroadPharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 BroadPharm Recent Developments
    11.12 CSNpharm
        11.12.1 CSNpharm Corporation Information
        11.12.2 CSNpharm Overview
        11.12.3 CSNpharm Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 CSNpharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 CSNpharm Recent Developments
    11.13 Merck
        11.13.1 Merck Corporation Information
        11.13.2 Merck Overview
        11.13.3 Merck Amifampridine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Merck Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Amifampridine Industry Chain Analysis
    12.2 Amifampridine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Amifampridine Production Mode & Process
    12.4 Amifampridine Sales and Marketing
        12.4.1 Amifampridine Sales Channels
        12.4.2 Amifampridine Distributors
    12.5 Amifampridine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Amifampridine Industry Trends
    13.2 Amifampridine Market Drivers
    13.3 Amifampridine Market Challenges
    13.4 Amifampridine Market Restraints
14 Key Findings in The Global Amifampridine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Amifampridine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Generic
    Table 3. Major Manufacturers of Patent
    Table 4. Global Amifampridine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Amifampridine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Amifampridine Sales by Region (2017-2022) & (K Units)
    Table 7. Global Amifampridine Sales Market Share by Region (2017-2022)
    Table 8. Global Amifampridine Sales by Region (2023-2028) & (K Units)
    Table 9. Global Amifampridine Sales Market Share by Region (2023-2028)
    Table 10. Global Amifampridine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Amifampridine Revenue Market Share by Region (2017-2022)
    Table 12. Global Amifampridine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Amifampridine Revenue Market Share by Region (2023-2028)
    Table 14. Global Amifampridine Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Amifampridine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Amifampridine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Amifampridine Revenue Share by Manufacturers (2017-2022)
    Table 18. Amifampridine Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Amifampridine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Amifampridine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifampridine as of 2021)
    Table 21. Amifampridine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Amifampridine Product Offered
    Table 23. Date of Manufacturers Enter into Amifampridine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Amifampridine Sales by Type (2017-2022) & (K Units)
    Table 26. Global Amifampridine Sales by Type (2023-2028) & (K Units)
    Table 27. Global Amifampridine Sales Share by Type (2017-2022)
    Table 28. Global Amifampridine Sales Share by Type (2023-2028)
    Table 29. Global Amifampridine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Amifampridine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Amifampridine Revenue Share by Type (2017-2022)
    Table 32. Global Amifampridine Revenue Share by Type (2023-2028)
    Table 33. Amifampridine Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Amifampridine Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Amifampridine Sales by Application (2017-2022) & (K Units)
    Table 36. Global Amifampridine Sales by Application (2023-2028) & (K Units)
    Table 37. Global Amifampridine Sales Share by Application (2017-2022)
    Table 38. Global Amifampridine Sales Share by Application (2023-2028)
    Table 39. Global Amifampridine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Amifampridine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Amifampridine Revenue Share by Application (2017-2022)
    Table 42. Global Amifampridine Revenue Share by Application (2023-2028)
    Table 43. Amifampridine Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Amifampridine Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Amifampridine Sales by Type (2017-2022) & (K Units)
    Table 46. North America Amifampridine Sales by Type (2023-2028) & (K Units)
    Table 47. North America Amifampridine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Amifampridine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Amifampridine Sales by Application (2017-2022) & (K Units)
    Table 50. North America Amifampridine Sales by Application (2023-2028) & (K Units)
    Table 51. North America Amifampridine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Amifampridine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Amifampridine Sales by Country (2017-2022) & (K Units)
    Table 54. North America Amifampridine Sales by Country (2023-2028) & (K Units)
    Table 55. North America Amifampridine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Amifampridine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Amifampridine Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Amifampridine Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Amifampridine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Amifampridine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Amifampridine Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Amifampridine Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Amifampridine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Amifampridine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Amifampridine Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Amifampridine Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Amifampridine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Amifampridine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Amifampridine Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Amifampridine Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Amifampridine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Amifampridine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Amifampridine Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Amifampridine Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Amifampridine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Amifampridine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Amifampridine Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Amifampridine Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Amifampridine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Amifampridine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Amifampridine Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Amifampridine Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Amifampridine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Amifampridine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Amifampridine Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Amifampridine Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Amifampridine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Amifampridine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Amifampridine Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Amifampridine Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Amifampridine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Amifampridine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Amifampridine Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Amifampridine Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Amifampridine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Amifampridine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Amifampridine Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Amifampridine Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Amifampridine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Amifampridine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Amifampridine Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Amifampridine Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Amifampridine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Amifampridine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Jacobus Pharmaceutical Corporation Information
    Table 106. Jacobus Pharmaceutical Description and Major Businesses
    Table 107. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Jacobus Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Jacobus Pharmaceutical Recent Developments
    Table 110. Unichem Corporation Information
    Table 111. Unichem Description and Major Businesses
    Table 112. Unichem Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Unichem Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Unichem Recent Developments
    Table 115. BioMarin Pharmaceutical Corporation Information
    Table 116. BioMarin Pharmaceutical Description and Major Businesses
    Table 117. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. BioMarin Pharmaceutical Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. BioMarin Pharmaceutical Recent Developments
    Table 120. Wockhardt Corporation Information
    Table 121. Wockhardt Description and Major Businesses
    Table 122. Wockhardt Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Wockhardt Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Wockhardt Recent Developments
    Table 125. Glenmark Pharmaceuticals Corporation Information
    Table 126. Glenmark Pharmaceuticals Description and Major Businesses
    Table 127. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Glenmark Pharmaceuticals Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Glenmark Pharmaceuticals Recent Developments
    Table 130. Norris Pharm Corporation Information
    Table 131. Norris Pharm Description and Major Businesses
    Table 132. Norris Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Norris Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Norris Pharm Recent Developments
    Table 135. BLD Pharm Corporation Information
    Table 136. BLD Pharm Description and Major Businesses
    Table 137. BLD Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. BLD Pharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. BLD Pharm Recent Developments
    Table 140. Biosynth AG Corporation Information
    Table 141. Biosynth AG Description and Major Businesses
    Table 142. Biosynth AG Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Biosynth AG Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Biosynth AG Recent Developments
    Table 145. Innovapharm Corporation Information
    Table 146. Innovapharm Description and Major Businesses
    Table 147. Innovapharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Innovapharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Innovapharm Recent Developments
    Table 150. Founder Pharma Corporation Information
    Table 151. Founder Pharma Description and Major Businesses
    Table 152. Founder Pharma Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Founder Pharma Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Founder Pharma Recent Developments
    Table 155. BroadPharm Corporation Information
    Table 156. BroadPharm Description and Major Businesses
    Table 157. BroadPharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. BroadPharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. BroadPharm Recent Developments
    Table 160. CSNpharm Corporation Information
    Table 161. CSNpharm Description and Major Businesses
    Table 162. CSNpharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. CSNpharm Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. CSNpharm Recent Developments
    Table 165. Merck Corporation Information
    Table 166. Merck Description and Major Businesses
    Table 167. Merck Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Merck Amifampridine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Merck Recent Developments
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Amifampridine Distributors List
    Table 173. Amifampridine Customers List
    Table 174. Amifampridine Market Trends
    Table 175. Amifampridine Market Drivers
    Table 176. Amifampridine Market Challenges
    Table 177. Amifampridine Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Amifampridine Product Picture
    Figure 3. Global Amifampridine Market Share by Type in 2021 & 2028
    Figure 3. Generic Product Picture
    Figure 4. Patent Product Picture
    Figure 5. Global Amifampridine Market Share by Application in 2021 & 2028
    Figure 6. Myasthenia Gravis
    Figure 7. Potassium Channel Blocker
    Figure 8. Amifampridine Report Years Considered
    Figure 9. Global Amifampridine Sales 2017-2028 (K Units)
    Figure 10. Global Amifampridine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Amifampridine Revenue 2017-2028 (US$ Million)
    Figure 12. Global Amifampridine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Amifampridine Sales Market Share by Region (2017-2022)
    Figure 14. Global Amifampridine Sales Market Share by Region (2023-2028)
    Figure 15. North America Amifampridine Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Amifampridine Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Amifampridine Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Amifampridine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Amifampridine Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Amifampridine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Amifampridine Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Amifampridine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Amifampridine Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Amifampridine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Amifampridine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Amifampridine in the World: Market Share by Amifampridine Revenue in 2021
    Figure 27. Global Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Amifampridine Sales Market Share by Type (2017-2028)
    Figure 29. Global Amifampridine Revenue Market Share by Type (2017-2028)
    Figure 30. Global Amifampridine Sales Market Share by Application (2017-2028)
    Figure 31. Global Amifampridine Revenue Market Share by Application (2017-2028)
    Figure 32. North America Amifampridine Sales Market Share by Type (2017-2028)
    Figure 33. North America Amifampridine Revenue Market Share by Type (2017-2028)
    Figure 34. North America Amifampridine Sales Market Share by Application (2017-2028)
    Figure 35. North America Amifampridine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Amifampridine Sales Share by Country (2017-2028)
    Figure 37. North America Amifampridine Revenue Share by Country (2017-2028)
    Figure 38. United States Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Amifampridine Sales Market Share by Type (2017-2028)
    Figure 41. Europe Amifampridine Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Amifampridine Sales Market Share by Application (2017-2028)
    Figure 43. Europe Amifampridine Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Amifampridine Sales Share by Country (2017-2028)
    Figure 45. Europe Amifampridine Revenue Share by Country (2017-2028)
    Figure 46. Germany Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 47. France Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Amifampridine Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Amifampridine Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Amifampridine Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Amifampridine Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Amifampridine Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Amifampridine Revenue Share by Region (2017-2028)
    Figure 57. China Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 60. India Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Amifampridine Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Amifampridine Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Amifampridine Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Amifampridine Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Amifampridine Sales Share by Country (2017-2028)
    Figure 71. Latin America Amifampridine Revenue Share by Country (2017-2028)
    Figure 72. Mexico Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Amifampridine Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Amifampridine Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Amifampridine Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Amifampridine Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Amifampridine Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Amifampridine Revenue Share by Country (2017-2028)
    Figure 81. Turkey Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Amifampridine Revenue (2017-2028) & (US$ Million)
    Figure 84. Amifampridine Value Chain
    Figure 85. Amifampridine Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed